These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 302271)

  • 1. The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
    Troye M; Perlmann P; Pape GR; Spiegelberg HL; Näslund I; Gidlöf A
    J Immunol; 1977 Sep; 119(3):1061-7. PubMed ID: 302271
    [No Abstract]   [Full Text] [Related]  

  • 2. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
    Troye M; Pape GR
    Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
    Pape GR; Troye M; Perlmann P
    J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of IgG-dependent K(killer) cells of peripheral blood in a tumor system].
    Pape GR; Troye M; Perlmann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1220-3. PubMed ID: 306169
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes.
    Pape GR; Troye M; Axelsson B; Perlmann P
    J Immunol; 1979 Jun; 122(6):2251-60. PubMed ID: 448127
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of human IgG to cultured urogenital tumor cells.
    Wright GL; Beckett ML; Campbell AE; Gardner KG; Somers KD
    J Natl Cancer Inst; 1987 Jun; 78(6):1061-8. PubMed ID: 3473247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM-induced cell-mediated cytotoxicity with antibody and effector cells of human origin.
    Fuson EW; Lamon EW
    J Immunol; 1977 May; 118(5):1907-9. PubMed ID: 576872
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-mediated target cell lysis by nonimmune cells: the use of anti-immunoglobulin to distinguish effector cell population.
    Resch K; Gelfand EW; Prester M
    J Immunol; 1974 Feb; 112(2):792-803. PubMed ID: 4544363
    [No Abstract]   [Full Text] [Related]  

  • 10. The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes.
    Jensenius JC; Williams AF
    Eur J Immunol; 1974 Feb; 4(2):91-7. PubMed ID: 4546942
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation of lymphoid cells: the use of specific antisera to characterize the cells required for the induction of immunoglobulin M production in vitro.
    Zimmerman DH; Okumura K; Rabkin C; Kern M
    J Immunol; 1974 Dec; 113(6):1891-6. PubMed ID: 4473487
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular immune response of bladder tumor patients: effects of aging on cytotoxic activity against T24].
    Kato M
    Hinyokika Kiyo; 1988 Aug; 34(8):1363-9. PubMed ID: 3195404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.
    Spiegelberg HL; Perlmann H; Perlmann P
    J Immunol; 1976 Nov; 117(5 Pt 1):1464-71. PubMed ID: 1002986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW; O'Toole C
    Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxins and immunologic unresponsiveness.
    Gelfand EW; Parkman R; Rosen FS
    Birth Defects Orig Artic Ser; 1975; 11(1):158-62. PubMed ID: 50094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and analysis of tumor immunity using anti-idiotypic antibodies.
    Hellström KE; Lee V; Nelson K; Hellström I
    Monogr Allergy; 1987; 22():212-21. PubMed ID: 3501835
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.